Showing results (2381-2390 of 3,755) with videos related to
Sort By:
Pageof 376
Neuromuscular Disorders : NMD|July 2, 2021
Reliability and validity of the FSHD-composite outcome measure in childhood facioscapulohumeral dystrophyK de Valle, F Dobson, I Woodcock, et al.Physiotherapy|February 7, 2020
Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF) as a measure of physical activity (PA) in young people with cerebral palsy: A cross-sectional studyGrace Lavelle, Marika Noorkoiv, Nicola Theis, et al.PM & R : the Journal of Injury, Function, and Rehabilitation|September 18, 2012
The impact of comorbidities and complications on burn injury inpatient rehabilitation outcomesJeffrey C Schneider, Paul Gerrard, Richard Goldstein, et al.Molecular Oncology|April 4, 2024
DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLCChristopher E Grant, Amy L Flis, Leila Toulabi, et al.Developmental Medicine and Child Neurology|March 5, 2026
Mental health difficulties in cerebral palsy: A qualitative study of young people's and parents' perspectivesManjula Manikandan, Jennifer Fortune, Jessica Burke, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratiosS D Thompson, L K Luyrink, T B Graham, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|September 24, 2011
Outcomes and predictors in burn rehabilitationWei-Han Tan, Richard Goldstein, Paul Gerrard, et al.Physical Therapy|June 4, 2019
Predictors of Walking Efficiency in Children With Cerebral Palsy: Lower-Body Joint Angles, Moments, and PowerMarika Noorkoiv, Grace Lavelle, Nicola Theis, et al.The European Respiratory Journal|May 1, 1993
Parenchymal emphysema measured by CT lung density correlates with lung function in patients with bullous diseaseG A Gould, A T Redpath, M Ryan, et al.Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer diseaseL M Bierer, P S Aisen, M Davidson, et al.Pageof 376